- 25428-98-2Isododecanol (9CI)
- 25431-45-21-Nonene,3,3,4,4,5,5,6,6,7,7,8,8,9,9,9-pentadecafluoro-
- 25436-07-1Acetic acid,2,2,2-trichloro-, trimethylsilyl ester
- 25437-94-94-(4-Hydroxy-1-piperidinyl)ethyl benzoate
- 25438-37-31-(Trimethylsiloxy)phenylacetonitrile
- 25440-14-621H,23H-Porphine,5,10,15,20-tetrakis(2,3,4,5,6-pentafluorophenyl)-
- 2544-05-0Propanoic acid,2-chloro-3-methoxy-
- 2544-06-1Propanoic acid,3-methoxy-
- 25441-16-1Benzenemethanol, a-[1-[methyl(3-phenyl-2-propen-1-yl)amino]ethyl]-,hydrochloride (1:1)
- 2544-13-0Benzenepropanenitrile, alpha-amino-3,4-dimethoxy-alpha-methyl-, hydrochloride (1:1), (alphaS)-
Hot Products
- 104987-11-3Tacrolimus
- 141-53-7Sodium formate
- 8001-54-5Quaternary ammonium compounds, alkylbenzyldimethyl, chlorides
- 9003-39-8Povidone
- 10161-34-9Trenbolone acetate
- 402957-28-2Telaprevir
- 68-19-9Cyanocobalamin
- 7631-86-9Silicon dioxide
- 302-79-4Tretinoin
- 77-92-9Citric acid
|
Basic Information |
|
Post buying leads |
|
Suppliers |
| Name |
Citreoviridin |
EINECS | N/A |
| CAS No. | 25425-12-1 | Density | 1.18g/cm3 |
| PSA | 89.13000 | LogP | 3.31800 |
| Solubility | N/A | Melting Point |
107-111℃ |
| Formula | C23H30 O6 | Boiling Point | 585.1°Cat760mmHg |
| Molecular Weight | 402.488 | Flash Point | 197.7°C |
| Transport Information | N/A | Appearance | N/A |
| Safety | Poison by ingestion, subcutaneous, and intraperitoneal routes. When heated to decomposition it emits acrid smoke and irritating fumes. | Risk Codes | 63-23/24/25-36/37/38 |
| Molecular Structure |
|
Hazard Symbols | T |
| Synonyms |
2,4,6,8,10,12-Tridecahexaenoicacid,5-hydroxy-3-methoxy-4,12-dimethyl-13-(tetrahydro-3,4-dihydroxy-2,4,5-trimethyl-2-furyl)-,d-lactone (7CI); 2H-Pyran-2-one,4-methoxy-5-methyl-6-[7-methyl-8-(tetrahydro-3,4-dihydroxy-2,4,5-trimethyl-2-furanyl)-1,3,5,7-octatetraenyl]-,[2S-[2a(1E,3E,5E,7E),3b,4a,5a]]-; 2H-Pyran-2-one,4-methoxy-5-methyl-6-[7-methyl-8-(tetrahydro-3,4-dihydroxy-2,4,5-trimethyl-2-furyl)-1,3,5,7-octatetraenyl]-(8CI); D-Iditol,2,5-anhydro-1,6-dideoxy-2-C-[(1E,3E,5E,7E)-8-(4-methoxy-5-methyl-2-oxo-2H-pyran-6-yl)-2-methyl-1,3,5,7-octatetraenyl]-4-C-methyl-(9CI); Citreoviridin; Citreoviridin A; Citreoviridine; Citreoviridine A |
Citreoviridin Chemical Properties
IUPAC Name: 6-[(1E,3E,5E,7E)-8-[(2S,3R,4R,5R)-3,4-Dihydroxy-2,4,5-trimethyloxolan-2-yl]-7-methylocta-1,3,5,7-tetraenyl]-4-methoxy-5-methylpyran-2-one
Synonyms of Citreoviridin (CAS NO.25425-12-1) : 2H-Pyran-2-one, 4-methoxy-5-methyl-6-(7-methyl-8-(tetrahydro-3,4-dihydroxy-2,4,5-trimethyl-2-furanyl)-1,3,5,7-octatetraenyl)- ; 4-Methoxy-5-methyl-6-(7-methyl-8-(tetrahydro-3,4-dihydroxy-2,4,5-trimethyl-2-furyl)-1,3,5,7-octatetraenyl)-2H-pyran-2-one ; Citreoviridin A
CAS NO:25425-12-1
Molecular Formula:C23H30O6
Molecular Weight :402.4807
Molecular Structure :.png)
Index of Refraction: 1.569
Surface Tension: 47.4 dyne/cm
Density: 1.18 g/cm3
Flash Point: 197.7 °C
Enthalpy of Vaporization: 100.35 kJ/mol
Boiling Point: 585.1 °C at 760 mmHg
Vapour Pressure: 3.97E-16 mmHg at 25°C
Appearance:Orange-yellow powder
Solubility:Citreoviridin is soluble in benzene, ethanol, chloroform, ether, dichloromethane.
Water solubility: Citreoviridin (CAS NO.25425-12-1) is hardly soluble in water (enough to give it yellow color) and hexane
Citreoviridin Uses
As other Aurovertin group members, Citreoviridin binds to and inhibit mitochondrial ATPase, thereby uncoupling oxidative phosphorylation. Citreoviridin (CAS NO.25425-12-1) are used as biochemical tools.
Citreoviridin Toxicity Data With Reference
| Organism | Test Type | Route | Reported Dose (Normalized Dose) | Effect | Source |
|---|---|---|---|---|---|
| mouse | LD50 | intraperitoneal | 7200ug/kg (7.2mg/kg) | PERIPHERAL NERVE AND SENSATION: FLACCID PARALYSIS WITHOUT ANESTHESIA (USUALLY NEUROMUSCULAR BLOCKAGE) BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD LUNGS, THORAX, OR RESPIRATION: OTHER CHANGES | Japanese Journal of Experimental Medicine. Vol. 42, Pg. 91, 1972. |
| mouse | LD50 | oral | 29mg/kg (29mg/kg) | PERIPHERAL NERVE AND SENSATION: FLACCID PARALYSIS WITHOUT ANESTHESIA (USUALLY NEUROMUSCULAR BLOCKAGE) BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD LUNGS, THORAX, OR RESPIRATION: OTHER CHANGES | Japanese Journal of Experimental Medicine. Vol. 42, Pg. 91, 1972. |
| mouse | LD50 | subcutaneous | 9600ug/kg (9.6mg/kg) | BEHAVIORAL: CHANGES IN MOTOR ACTIVITY (SPECIFIC ASSAY) LUNGS, THORAX, OR RESPIRATION: DYSPNEA | Research Communications in Chemical Pathology and Pharmacology. Vol. 59, Pg. 31, 1988. |
| rabbit | LD50 | intraperitoneal | > 40mg/kg (40mg/kg) | Research Communications in Chemical Pathology and Pharmacology. Vol. 59, Pg. 31, 1988. | |
| rabbit | LD50 | intravenous | 5mg/kg (5mg/kg) | Research Communications in Chemical Pathology and Pharmacology. Vol. 59, Pg. 31, 1988. | |
| rat | LD50 | subcutaneous | 3600ug/kg (3.6mg/kg) | PERIPHERAL NERVE AND SENSATION: FLACCID PARALYSIS WITHOUT ANESTHESIA (USUALLY NEUROMUSCULAR BLOCKAGE) LUNGS, THORAX, OR RESPIRATION: OTHER CHANGES | Japanese Journal of Experimental Medicine. Vol. 42, Pg. 91, 1972. |
| rat | LDLo | intraperitoneal | 4100ug/kg (4.1mg/kg) | Japanese Journal of Experimental Medicine. Vol. 42, Pg. 91, 1972. | |
| rat | LDLo | oral | 8mg/kg (8mg/kg) | Japanese Journal of Experimental Medicine. Vol. 42, Pg. 91, 1972. |
Citreoviridin Consensus Reports
EPA Genetic Toxicology Program.
Citreoviridin Safety Profile
Poison by ingestion, subcutaneous, and intraperitoneal routes. When Citreoviridin (CAS NO.25425-12-1) is heated to decomposition it emits acrid smoke and irritating fumes.
RIDADR 3172
HazardClass 6.1(a)
PackingGroup II
What can I do for you?
Get Best Price
